The Brugada syndrome

Current Opinion in Cardiology

Volumn 17, Issue 1, 2002, Pages 19-23

  Naccarelli, Gerald V ^a   Antzelevitch, Charles ^a   Wolbrette, Deborah L ^a   Luck, Jerry C ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT;

BRUGADA SYNDROME; CLINICAL GENETICS; ELECTROCARDIOGRAPHY; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE FIBRILLATION; HUMAN; MOLECULAR BIOLOGY; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; ST SEGMENT ELEVATION;

BUNDLE-BRANCH BLOCK; COMBINED MODALITY THERAPY; DEFIBRILLATORS, IMPLANTABLE; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HEART CONDUCTION SYSTEM; HUMANS; PROGNOSIS; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; SYNDROME; VENTRICULAR FIBRILLATION;

EID: 0036148980     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200201000-00003     Document Type: Review

References (47)

1. Idiopathic ventricular tachycardia and fibrillation
2. Sudden cardiac death in persons with normal (or near normal) hearts
3. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome: A multicenter report
4. Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation
5. Cardiac Na(+) channel dysfunction in Brugada syndrome is aggravated by beta(1)-subunit
6. The Brugada syndrome: Clinical, electrophysiological and genetic aspects
7. The Brugada syndrome
8. Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome
9. The molecular genetics of arrhythmias and sudden death
10. Molecular mechanism for an inherited cardiac arrhythmia
11. Two distinct congenital arrhythmias evoked by a multidysfunctionall Na(+) channel
12. Cardiac arrhythmias: The genetic connection
13. Cardiac conduction defects associate with mutations in SCN5A
14. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
15. The Brugada syndrome: Clinical, genetic, cellular, and molecular abnormalities
16. Cellular basis for the electrocardiographic J wave
17. Cellular basis for the Brugada Syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation
18. Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia. The antiarrhythmic effects of 4-aminopyridine
19. The Brugada syndrome: Ionic basis and arrhythmia mechanisms
20. Autonomic and antiarrhythmic drug moduration of ST segment elevation in patients with Brugada syndrome
21. Dynamic changes of 12-lead electrocardiograms in a patient with Brugada syndrome
22. Discrepant drug action of disopyramide on ECG abnormalities and induction of ventricular arrhythmias in a patient with Brugada syndrome
23. The elusive link between LQT3 and Brugada syndrome: The role of flecainide challenge
24. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts
25. to and action potential notch are smaller in left vs. right canine ventricular epicardium
26. Rate dependence of action potential duration and refractoriness in canine ventricular endocardium differs from that of epicardium: The role of the transient outward current
27. Ion channels and ventricular arrhythmias. Cellular and ionic mechanisms underlying the Brugada syndrome
28. Heterogeneity within the ventricular wall: Electrophysiology and pharmacology of epicardial, endocardial and M cells
29. Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome
30. 'Brugada' syndrome: Clinical data and suggested pathophysiological mechanism
31. Electrocardiographic pattern simulating acute myocardial injury
32. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men
33. Ventricular fibrillation causes sudden death in Southeast Asian immigrants
34. 3. A marker for sudden death in patients without demonstrable structural heart disease
35. A survey in the incidence of right bundle branch block with ST elevation among normal population
36. Prevalence of the Brugada syndrome in an apparently healthy population
37. Three year follow-up of patients with right bundle branch block and ST segment elevation in the right precordial leads
38. Accurate noninvasive evaluation and genetic screening could help in differentiating congenital Brugada's syndrome from the acquired one, secondary to right ventricular dysplasia cardiomyopathy
39. Localized right ventricular morphological abnormalities detected by electron-beam computed tomography represent arrhythmogenic substrates in patients with the Brugada syndrome
40. Brugada syndrome and supraventricular tachyarrhythmias: A novel association?
41. Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: Insight into risk stratification
42. Clinical and genetic heterogeneity of right bundle branch block and ST- segment elevation syndrome: A prospective evaluation of 52 families
43. Possible bradycardic mode of death and successful pacemaker treatment in a large family with features of long QT syndrome type 3 and Brugada syndrome
44. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy
45. Clinical diagnosis and risk stratification in patients with Brugada syndrome
46. Sudden death in high-risk family members: Brugada syndrome
47. Long QT and Brugada syndromes: From genetics to clinical management